Product correctly added to cart.

discount label
(2-Ethylpyridin-3-yl)methanol
View 3D

Biosynth logo

(2-Ethylpyridin-3-yl)methanol

CAS: 15440-72-9

Ref. 3D-QAA44072

25mg
257.00 €
250mg
1,023.00 €
Estimated delivery in United States, on Tuesday 7 Jan 2025

Product Information

Name:
(2-Ethylpyridin-3-yl)methanol
Description:

(2-Ethylpyridin-3-yl)methanol is a drug that can be used for the treatment of cerebral ischemia. It has been shown to increase blood flow to the brain and reduce the infarct size in animal models. (2-Ethylpyridin-3-yl)methanol is also effective in treating acute ischemic stroke, as it has been shown to reduce the severity of cerebral vasospasm. This drug can be used as a substitute for insulin in type 2 diabetes mellitus, because it reduces insulin resistance and improves glycemic control. As with other drugs in this class, (2-Ethylpyridin-3-yl)methanol should be administered by intravenous infusion only. The recommended dose for adults with normal renal function is 3 mg/kg body weight over 15 minutes followed by an infusion at 0.5 mg/kg over 4 hours. If given as an infusion,

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
137.18 g/mol
Formula:
C8H11NO
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-QAA44072 (2-Ethylpyridin-3-yl)methanol

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".